After Pfiser's booster shot approval this month, MRNA will surely follow. Today, they announced a combined flu and COVID shot, as well as signing a multi-year deal with a manufacturer, National Risilience Inc, which will help reach its 2021 goal of delivering 800M-1B doses of its vaccine.
This has got the stock soaring and the rim of the cup is forming as you can see in my beautiful drawings. At least that's what my mom calls them.
So, get ready for a pullback and then a trip to the moon! 😉🚀🚀🚀
That is not a cup & handle, frankly looks like a textbook Bump & Run Reversal pattern
alxiv
⋅
@josiason17420, Interesting. Where do you see the bump ?
Bobpnmicro
⋅
It has the same market cap as Merck . You are out of your mind if you buy or don't at least take profit at this point . I wouldn't say short cause as Warren Buffet himself said the manipulation can go on way longer than expected but eventually it will come back to earth .
Tazatron
⋅
@Bobpnmicro, Merck is a horse and buggy technology, MRNA is automized, we are talking about a whole new way of developing, manufacturing and administering the vaccine, so it's natural that MRNA eclipse Merck several times over, yet with all that MRNA is super cheap only trading at 15 FPE.
mariyan15135931
⋅
@Bobpnmicro, exactlly . well said . Just wait for you resistance levels and short momrntum